R14	Anaphora Anaphor:T180 Antecedent:T173
R15	Anaphora Anaphor:T198 Antecedent:T200
R16	Anaphora Anaphor:T229 Antecedent:T228
R17	Anaphora Anaphor:T234 Antecedent:T106
R18	Anaphora Anaphor:T236 Antecedent:T113
R19	Anaphora Anaphor:T236 Antecedent:T112
R20	Anaphora Anaphor:T236 Antecedent:T10
R21	Anaphora Anaphor:T236 Antecedent:T146
R22	Anaphora Anaphor:T236 Antecedent:T144
R23	Anaphora Anaphor:T236 Antecedent:T145
R24	Anaphora Anaphor:T236 Antecedent:T114
R25	Anaphora Anaphor:T247 Antecedent:T142
T2	Drug_Class 2478 2512	agents that cause vasoconstriction
T37	Drug 2522 2535	phenylephrine
T38	Drug 2537 2546	ephedrine
T39	Drug 2548 2565	dihydroergotamine
T40	Drug 2567 2586	phenylpropanolamine
T41	Drug 2591 2606	pseudoephedrine
T36	Drug 2434 2444	ProAmatine
T45	Drug_Class 2791 2809	cardiac glycosides
T46	Drug 2819 2828	digitalis
T4	Drug_Class 2882 2934	agents that directly or indirectly reduce heart rate
T47	Drug_Class 2831 2857	psychopharmacologic agents
T48	Drug_Class 2859 2872	beta blockers
T44	Drug 2753 2763	ProAmatine
T59	Drug 3472 3495	fludrocortisone acetate
T57	Drug 3303 3313	ProAmatine
T19	Drug_Class 4235 4270	agents in over-the-counter products
T18	Drug_Class 4280 4293	cold remedies
T80	Drug_Class 4298 4307	diet aids
T21	Drug 4452 4462	ProAmatine
T89	Drug 5108 5118	ProAmatine
T90	Drug_Class 5120 5138	cardiac glycosides
T30	Drug_Class 5216 5263	drugs that stimulate alpha-adrenergic receptors
T91	Drug 5271 5284	phenylephrine
T92	Drug 5286 5301	pseudoephedrine
T93	Drug 5303 5312	ephedrine
T94	Drug 5314 5333	phenylpropanolamine
T95	Drug 5337 5354	dihydroergotamine
T97	Drug 5405 5415	ProAmatine
T32	Drug_Class 5602 5632	salt-retaining steroid therapy
T101	Drug 5640 5663	fludrocortisone acetate
T100	Drug 5538 5548	ProAmatine
T105	Drug 5934 5944	ProAmatine
T104	Drug 5842 5865	fludrocortisone acetate
T110	Drug 6054 6064	ProAmatine
T106	Drug_Class 5946 5978	Alpha-adrenergic blocking agents
T107	Drug 5988 5996	prazosin
T108	Drug 5998 6007	terazosin
T109	Drug 6013 6022	doxazosin
T111	Drug_Class 5502 5536	agents that cause vasoconstriction
T112	Drug 6428 6437	quinidine
T113	Drug 6361 6371	cimetidine
T114	Drug 6412 6422	flecainide
T115	Drug 26 36	ProAmatine
T116	Drug 96 106	ProAmatine
T117	Drug 286 296	ProAmatine
T118	Drug 615 625	ProAmatine
T119	Drug 742 752	ProAmatine
T120	Drug 895 905	ProAmatine
T121	Drug 1083 1093	ProAmatine
T122	Drug 1275 1285	ProAmatine
T123	Drug 1601 1611	ProAmatine
T124	Drug 1695 1705	ProAmatine
T125	Drug 1803 1813	ProAmatine
T126	Drug 1931 1941	ProAmatine
T127	Drug 2677 2687	ProAmatine
T128	Drug 3103 3113	ProAmatine
T129	Drug 3142 3152	ProAmatine
T130	Drug 3571 3581	ProAmatine
T131	Drug 3757 3767	ProAmatine
T132	Drug 3954 3964	ProAmatine
T133	Drug 3966 3976	ProAmatine
T134	Drug 4039 4049	ProAmatine
T135	Drug 4383 4393	ProAmatine
T136	Drug 4711 4721	ProAmatine
T137	Drug 5456 5466	ProAmatine
T138	Drug 6761 6771	ProAmatine
T139	Drug 6822 6832	ProAmatine
T140	Drug 7014 7024	ProAmatine
T141	Drug 7073 7083	ProAmatine
T142	Drug 7390 7400	ProAmatine
T143	Drug 7739 7749	ProAmatine
T144	Drug 6385 6397	procainamide
T145	Drug 6399 6410	triamterene
T146	Drug 6373 6383	ranitidine
T7	Substance 6208 6224	desyglymidodrine
T10	Drug 6350 6359	metformin
T250	SPAN 79 86	Warning
T251	SPAN 4489 4497	Patients
T153	ZeroArticleNP 0 10	Drug Label
T154	ZeroArticleNP 15 36	drug brand ProAmatine
T155	PersonalPronoun 160 162	it
T156	DefiniteNP 260 274	The indication
T157	DefiniteNP 300 313	the treatment
T158	IndefiniteNP 375 383	a change
T159	IndefiniteNP 387 405	a surrogate marker
T160	IndefiniteNP 424 435	an increase
T161	IndefiniteNP 499 517	a surrogate marker
T162	IndefiniteNP 553 571	a clinical benefit
T163	DefiniteNP 1021 1066	The most potentially serious adverse reaction
T164	ZeroArticleNP 1083 1101	ProAmatine therapy
T165	DemonstrativeNP 1310 1321	this degree
T166	DefiniteNP 1573 1592	the clinical trials
T167	DemonstrativeNP 1539 1553	those patients
T168	DemonstrativeNP 1615 1628	such patients
T169	ZeroArticleNP 1695 1713	ProAmatine therapy
T170	PersonalPronoun 1715 1717	It
T171	DefiniteNP 1841 1854	The potential
T172	DefiniteNP 1914 1927	the beginning
T173	ZeroArticleNP 1931 1949	ProAmatine therapy
T174	DefiniteNP 2009 2020	the patient
T175	DefiniteNP 2069 2077	the head
T176	DefiniteNP 2081 2097	the bed elevated
T177	DefiniteNP 2099 2110	The patient
T178	DefiniteNP 2238 2246	the ears
T179	DefiniteNP 2279 2290	The patient
T180	DefiniteNP 2324 2338	the medication
T181	IndefiniteNP 2472 2512	other agents that cause vasoconstriction
T182	DefiniteNP 2628 2642	the heart rate
T183	IndefiniteNP 2608 2624	A slight slowing
T184	IndefiniteNP 2876 2934	other agents that directly or indirectly reduce heart rate
T185	ZeroArticleNP 2831 2857	psychopharmacologic agents
T186	ZeroArticleNP 2859 2872	beta blockers
T187	IndefiniteNP 2960 2969	any signs
T188	DefiniteNP 3251 3281	the alpha-adrenergic receptors
T189	DefiniteNP 3285 3301	the bladder neck
T190	IndefiniteNP 3423 3432	a history
T191	IndefiniteNP 3521 3532	an increase
T192	DefiniteNP 3684 3695	the kidneys
T193	IndefiniteNP 3836 3851	a starting dose
T194	DemonstrativeNP 3742 3755	such patients
T195	DefiniteNP 4118 4127	the liver
T196	DefiniteNP 4142 4156	the metabolism
T197	IndefiniteNP 4132 4138	a role
T198	PersonalPronoun 4398 4402	they
T199	DefiniteNP 4429 4448	the pressor effects
T200	ZeroArticleNP 4227 4270	certain agents in over-the-counter products
T201	ZeroArticleNP 4280 4293	cold remedies
T202	ZeroArticleNP 4468 4485	Drug Interactions
T203	DefiniteNP 4527 4542	the possibility
T204	PersonalPronoun 4567 4571	They
T205	PersonalPronoun 4617 4621	they
T206	PersonalPronoun 4669 4673	they
T207	PossessivePronoun 4603 4613	their dose
T208	PossessivePronoun 4686 4707	their last daily dose
T209	IndefiniteNP 4643 4653	any length
T210	PossessivePronoun 4891 4905	its metabolism
T211	DefiniteNP 4851 4862	the kidneys
T212	DefiniteNP 4867 4876	the liver
T213	DefiniteNP 4921 4932	the patient
T214	IndefiniteNP 4881 4887	a role
T215	ZeroArticleNP 5009 5016	therapy
T216	DefiniteNP 5205 5212	The use
T217	DefiniteNP 5382 5401	the pressor effects
T218	ZeroArticleNP 5216 5263	drugs that stimulate alpha-adrenergic receptors
T219	ZeroArticleNP 5502 5536	agents that cause vasoconstriction
T220	ZeroArticleNP 5602 5632	salt-retaining steroid therapy
T221	ZeroArticleNP 5682 5702	salt supplementation
T222	DefiniteNP 5704 5717	The potential
T223	DefiniteNP 5830 5838	the dose
T224	DefiniteNP 5880 5895	the salt intake
T225	DemonstrativeNP 5775 5789	these patients
T226	DefiniteNP 6039 6050	the effects
T227	ZeroArticleNP 5946 5978	Alpha-adrenergic blocking agents
T228	ZeroArticleNP 6081 6097	Drug Interaction
T229	PersonalPronoun 6099 6101	It
T230	DefiniteNP 6180 6204	the high renal clearance
T231	DefiniteNP 6272 6297	the base-secreting system
T232	DefiniteNP 6319 6332	the secretion
T233	IndefiniteNP 6226 6232	a base
T234	DemonstrativeNP 6336 6346	such drugs
T235	IndefiniteNP 6457 6468	a potential
T236	DemonstrativeNP 6501 6512	these drugs
T237	IndefiniteNP 6692 6705	a mg/m2 basis
T238	DefiniteNP 6795 6818	the mutagenic potential
T239	DefiniteNP 6882 6907	the dominant lethal assay
T240	DefiniteNP 6999 7010	the effects
T241	DefiniteNP 7094 7102	the rate
T242	DefiniteNP 7262 7284	the maximum human dose
T243	DefiniteNP 7441 7462	the potential benefit
T244	DefiniteNP 7473 7491	the potential risk
T245	DefiniteNP 7495 7504	the fetus
T246	PersonalPronoun 7598 7600	It
T247	DemonstrativeNP 7622 7631	this drug
T248	IndefiniteNP 7769 7784	a nursing woman
T249	ZeroArticleNP 7667 7677	many drugs
